valu usd unless otherwis note
view continu see sequenti improv perform
oper earn growth next year off-set one-tim item
tweak estim slightli lower pt
print show sign improv
adj ep line estim consensu consist
management guidanc result reflect sequenti improv
compani effort off-set lower pharmaci reimburs
challeng uk oper environ gain traction enabl
bounc back bottom
guidanc consist prior commentari
larg result unfavor comparison vs reduc bonus
higher tax rate management expect adj ep flat yoy
guidanc assum top-line growth core oper
earn growth spite increas pharmaci reimburs
pressur due higher number pbm contract renew
headwind increment invest headwind
remov e-cig
given known headwind step next year
expect continu improv script retail trend bake
guidanc would anticip healthi amount skeptic
investor compani abl deliv
anticip oper leverag top-line growth partli reflect
on-going cost reduct initi management see total save
transform manag program
prev save incorpor headcount reduct store
optim new polici manag extern resourc program
direct cost-to-fil shrink intend help enabl
invest growth addit management note rise confid abil
unlock work capit compani invest heavili new
pharmaci system expect help significantli reduc inventori
next three year
continu progress partnership pilot
alreadi see posit econom current labcorp
patient servic center locat target fedex
partnership compani also continu develop clinic
servic offer partnership partner primari
villagemd southwest medic primari care locat four
market note management outlook includ
signific benefit variou pilot initi
price prior trade day market close estimate unless otherwis note
bloomberg capit market estim upside/downside/target
target previous base
adjust ep repres discount two-year
averag peer group valuat essenti consist
current forward multipl believ discount valuat
reason consid on-going challeng face
compani articul well-defin
strategi begin demonstr success
expect investor assign significantli higher valuat
stock given near-term headwind like
limit near-term earn growth use basi
recogn manag confid sustain mid-
upsid scenario assum ep growth
come high end manag target long-
term rang mid-to-high singl digit reflect better-
than-expect abil off-set on-going challeng
oper environ analysi also assum
investor becom comfort manag
strategi compani abil execut valuat
multipl return peer group two-year averag
level
downsid scenario assum ep growth
come slightli manag long-term guidanc
unabl gener anticip top-lin growth
cost save analysi assum stock
valuat declin approxim discount rel
comp group two-year averag level
believ signific nation scale brand
posit benefit on-going shift toward
consumer healthcar provid care
patient conveni set focu qualiti
effici becom increasingli import
manag recogn evolv role commun
pharmaci import deliv broader suit
servic product focus health well
effort creat neighborhood health destin
form valuabl strateg partnership leverag
expertis leader import servic non-cor
compet compani import
opinion primari care partnership
could help posit compani well rapidli
proprietari analysi conjunct element
show solid overlap sever attract market
high densiti walgreen store strong
membership howev believ abil scale
partnership key ensur relev evolv
marketplac futur success
evid materi progress turnaround cost
reduct effort could result upward estim revis
believ well-defin strategi specif
financi target could improv market percept
stori valuat
resolut opioid litig exposur issu would remov
overhang share
improv clariti regard brexit could improv
consum environ boot uk
risk invest thesi
inabl gener anticip cost save could hamper
abil invest capit growth-ori
failur creat neighborhood health destin
target inabl scale model
no-deal brexit could weaken uk retail
amazon entri drug deliveri could impact revenu
earn growth rate pharmaci busi
deliv aug adjust ep line estim consensu
result consist manag expect reflect sequenti
improv follow compani disappoint print wba effort
off-set impact lower pharmaci reimburs challeng oper
environ uk continu gain traction
manag initi guidanc call adjust ep essenti flat yoy
constant currenc basi yoy growth oper perform
contribut buyback off-set higher tax rate headwind reinstat
full bonus headwind total revenu growth estim includ
continu solid script growth partli off-set store optim slightli higher
reimburs cut face increas number pbm contract renew
increasingli renew term vs histor core earn growth
consist manag long-term target adj ep growth mid-
high-singl digit also reflect benefit cost reduct partli off-set
yoy increas oper cost on-going invest digit
develop well impact remov e-cigarett store
save estim transform manag program increas
enterprise-wid streamlin initi launch earli expect ramp toward
run-rat save approxim previous make continu
stronger-than-expect progress across four key area smart spend smart
organ digit division optim improv visibl
long-term pipelin initi effort includ headcount reduct boot
uk headquart complet quarter closur
under-perform boot uk store complet quarter
remaind close addit manag increasingli confid abil
reduc work capit significantli save program better enabl
compani invest growth
yoy
top-line driven continu solid growth pharmaci yoy retail sale
includ continu neg impact store optim program
yoy
adj oi margin bp yoy partli reflect continu headwind select
invest store labor expens repres drag addit
face unfavor comparison due one-tim benefit adjust certain legal
accrual settlement yoy drag
adj gpm bp yoy larg reflect lower pharmaci reimburs howev
yoy margin contract improv vs previou quarter lever off-set continu
pharmaci reimburs pressur continu gain traction
primarili driven ss script growth ss script repres solid
improv rel
ss top-line also driven solid growth specialti yoy well brand inflat
manag expect remain partli off-set mid- high-singl
digit gener deflationari impact longer term
meanwhil wba pharmaci market share declin bp yoy larg result
store optim program
note yoy margin contract improv vs bp
bp
yoy declin continu reflect reimburs pressur headwind relat
strong growth specialti carri lower margin
de-emphasi tobacco approxim headwind
retail sale trajectori improv nice ss vs retail adj
gpm improv expect bp yoy adjust promot spend
yoy constant currenc
yoy declin reflect continu challeng oper environ particularli uk
top-line declin reflect lower script volum lower nh fund result time shift
year
boot hold share weak oper environ perform well
beauti categori retail comp worsen slightli first nine
yoy cc
adj oi margin declin bp yoy
previous note compani taken step address cost structur uk
includ headcount reduct complet on-going closur
under-perform store complet quarter remaind close
save anticip primarili recogn
recal store closur repres boot uk footprint mani store
involv lose money within walk distanc anoth boot store
anticip revenu impact closur
yoy cc
top-line perform wholesal remain strong led emerg market uk
busi custom contract chang ad bp yoy growth
yoy cc
adj oi margin bp yoy
price target base multipl adjust ep repres
approxim discount two-year averag peer group valuat essenti
consist current forward multipl believ discount valuat reason
consid on-going challeng face compani abl
articul well-defin strategi begin demonstr success
expect investor assign significantli higher valuat stock given near-term
headwind like limit near-term earn growth use basi
recogn manag confid sustain mid- high-single-digit ep growth
price target justifi sector perform rate
risk rate price target
may abl deliv anticip save transform
manag program hamper abil invest capit growth-ori
manag may find right mix product servic fail creat
neighborhood health destin target compani partner may
abl scale model quickli enough protect market share
uk retail environ could remain soft weaken undermin manag
effort reinvigor busi
on-going nation policy-driven effort reduc drug price could unintend
consequ retail pharmaci busi model
amazon could continu erod front-stor busi entri drug deliveri
could significantli reduc wba revenu earn growth rate pharmaci
largest retail pharmaci health daili live destin
across us europ walgreen boot allianc compani
equiti method invest togeth presenc countri employ
peopl compani global leader pharmacy-l health
well-b retail togeth equiti method invest
store countri well one largest global pharmaceut wholesal
distribut network distribut center deliv
pharmaci doctor health center hospit year
countri addit one world largest purchas
prescript drug mani health well-b product
sale
adj sg sale
equiti earn
